Citadel Advisors LLC 13D and 13G filings for Ventyx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 4,279,553 7.300% |
490,758 (+12.95%) |
Filing |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,788,795 6.700% |
-102,278 (-2.63%) |
Filing |
| 2022-02-14 06:26 am Purchase |
2021-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,891,073 7.700% |
455,133 (+13.25%) |
Filing |
| 2021-11-04 4:21 pm Purchase |
2021-10-25 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,435,940 6.800% |
3,435,940 (New Position) |
Filing |